Cipla proposal to market Plazomicin with clinical trial waiver rejected by CDSCO panel Medical Dialogues Team7 Dec 2021 6:37 PM ISTNew Delhi: Rejecting pharma major Cipla's proposal to import and market Plazomicin 50mg/ml injection with a local clinical trial waiver, the Subject...
Glenmark gets CDSCO panel nod to market Remogliflozin, Teneligliptin, Metformin FDC drug Medical Dialogues Team17 Nov 2021 4:59 PM ISTNew Delhi: Granting permission for a local Phase III clinical trial and bioequivalence study waver, the Subject Expert Committee (SEC) of the Central...
Dr Vishal R Tandon nominated as expert at CDSCO Medical Dialogues Team16 Nov 2021 7:06 PM ISTNew Delhi: The Ministry of Health and Family Welfare, Government of India has nominated Prof Dr Vishal R Tandon of Government Medical College Jammu as...
Glenmark gets CDSCO panel nod to import, market Akynzeo Medical Dialogues Team4 Nov 2021 11:30 AM ISTNew Delhi: Granting a local clinical trial waiver, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has...
Cadila Healthcare gets CDSCO panel nod to conduct phase 3 study of ZydCov-D in 2-dose schedule Medical Dialogues Team29 Sept 2021 4:47 PM ISTNew Delhi: In a major rejoice to Cadila Healthcare, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
Submit detailed rationale for developing Pantoprazole modified dosage form: CDSCO panel tells Lupin Medical Dialogues Team28 Sept 2021 6:01 PM ISTNew Delhi: In response to drug-maker Lupin's proposal of manufacturing and marketing Pantoprazole enteric coated delayed release tablets 40 mg...
Bharat Biotech Covaxin efficacy 77.8 percent, gets CDSCO panel okay Medical Dialogues Team23 Jun 2021 1:00 PM ISTNew Delhi: An expert panel of the country's central drugs authority has reviewed and accepted the phase-3 trial data of Bharat Biotech's COVID-19...
Include more Govt sites: CDSCO panel to Sanofi on clinical trial of pulmonary disease drug Medical Dialogues Team16 March 2021 9:00 AM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has granted permission to...
Entod Pharma directed to submit results of Phase-IV CT protocol on 25 patients to continue manufacturing Cataract FDC Medical Dialogues Team7 March 2021 12:30 PM ISTNew Delhi: Manufacturer of fixed-dose combination drug Tropicamide/Phenylephrine/Lidocaine Intracameral solution for injection (0.2mg/ml + 3.1mg/ml +...
Lincoln pharma told to revise package insert before launching Sildenafil Citrate Oral Spray in Indian market Medical Dialogues Team5 March 2021 12:17 PM ISTNew Delhi: Pharma Company, Lincoln Pharmaceuticals has been directed by the Central Drugs Standard Control Organization (CDSCO) Committee to revise...
Cadila Healthcare gets CDSCO panel go-ahead for Phase 3 trial of Novel Corona Virus 2019-nCoV Vaccine MD Bureau7 Jan 2021 5:28 PM ISTNew Delhi: Pharmaceutical major, Cadila Healthcare has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
AIDAN slams approval of Covaxin, expresses alarm over lack of efficacy, trial data Farhat Nasim5 Jan 2021 4:42 PM ISTNew Delhi: Slamming the recent approval of Covid-19 vaccine, Covaxin, developed by Bharat Biotech in association with the Indian Council of...
